These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 19210526
1. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression. Toniutto P, Minisini R, Fabris C, De Feo T, Marangoni F, Burlone M, Avellini C, Bitetto D, Fornasiere E, Fumolo E, Baccarani U, Pirisi M. Clin Transplant; 2009; 23(2):184-90. PubMed ID: 19210526 [Abstract] [Full Text] [Related]
2. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts. Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B. Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887 [Abstract] [Full Text] [Related]
3. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J. Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423 [Abstract] [Full Text] [Related]
5. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD. Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597 [Abstract] [Full Text] [Related]
6. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH. J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883 [Abstract] [Full Text] [Related]
9. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Segovia R, Sánchez-Fueyo A, Rimola A, Grande L, Bruguera M, Costa J, Soguero C, Uriz J. Liver Transpl; 2001 Feb; 7(2):106-12. PubMed ID: 11172393 [Abstract] [Full Text] [Related]
10. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN. Transplantation; 2007 Aug 15; 84(3):331-9. PubMed ID: 17700157 [Abstract] [Full Text] [Related]
16. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy. Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL. Liver Transpl; 2001 Jun 15; 7(6):513-7. PubMed ID: 11443579 [Abstract] [Full Text] [Related]
17. Dual hepatitis virus infections in liver transplant: case report and a review of the literature. Yataco ML, Dickson RC, Bonatti H, Aranda-Michel J, Mendez J, Ghabril M, Nguyen J. Clin Transplant; 2009 Jun 15; 23(2):282-8. PubMed ID: 19191801 [Abstract] [Full Text] [Related]
18. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. N Engl J Med; 1999 Jul 01; 341(1):22-6. PubMed ID: 10387938 [Abstract] [Full Text] [Related]